Prevalence of Psychiatric Problems Among Patients and Healthcare Providers in a Cardiology Department: A Cross-Sectional Study

December 8, 2025 updated by: Hossam Loly Abdulhameed Abdullah, Assiut University

Prevalence of Psychiatric Problems Among Patients and Healthcare Providers in the Department of Cardiovascular Medicine

The goal of this observational cross-sectional study is to determine the prevalence of psychiatric problems (depression, anxiety, stress, and burnout) among patients with cardiovascular diseases and healthcare providers working in the Department of Cardiovascular Medicine at Assiut University Heart Hospital.

The main questions it aims to answer are:

  • What is the prevalence of depression, anxiety, and stress among cardiovascular patients?
  • What is the prevalence of burnout, depression, and anxiety among healthcare providers in the same department?

The study will also explore potential sociodemographic, occupational, and clinical factors associated with these psychological outcomes.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide. Psychological comorbidities-such as depression, anxiety, post-traumatic stress disorder, and cognitive impairment-are highly prevalent among patients with CVD and are known to adversely affect treatment adherence, quality of life, and overall outcomes.

Similarly, healthcare professionals working in cardiovascular medicine are exposed to continuous psychological stress due to long working hours, critical decision-making, and frequent exposure to life-threatening situations. These stressors contribute to burnout, depression, anxiety, and reduced job satisfaction, all of which may negatively influence patient safety and workforce stability.

Despite the recognized importance of mental health in cardiology, limited data exist from low- and middle-income countries-particularly from Egypt-regarding the concurrent assessment of mental health among both patients and healthcare providers within the same clinical setting.

Therefore, this study aims to estimate the prevalence and correlates of psychiatric symptoms among cardiovascular patients and healthcare providers in a tertiary care center. The results are expected to guide the development of psychosocial support programs and promote mental health awareness in hospital cardiology departments.

Study Design:

Type: Cross-sectional, descriptive, hospital-based study

Setting: Assiut University Heart Hospital

Sample: ~380 cardiovascular patients (systematic random sampling) and all available healthcare providers (census approach)

Tools: Standardized and validated questionnaires including SCL-90R, PSS, PSQI, MBI, and COPE Inventory

Data Analysis: Descriptive and multivariate logistic regression analyses using SPSS v26

Study Type

Observational

Enrollment (Estimated)

380

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
    • Asyut Governorate
      • Asyut, Asyut Governorate, Egypt, 71515
        • Assiut University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Adults with cardiovascular diseases admitted to or attending the outpatient clinics of the Cardiology Department at Assiut University Heart Hospital, and healthcare providers (physicians, residents, nurses, and technicians) currently working in the same department.

Description

Inclusion Criteria:

Patients

Age ≥ 18 years. Diagnosed with a cardiovascular disease (e.g., ischemic heart disease, heart failure, valvular disease).

Able to understand and complete self-administered questionnaires or participate in structured interviews.

Provided informed written consent.

Healthcare Providers

Physicians, residents, nurses, or allied staff working in the Department of Cardiovascular Medicine for ≥6 months.

Provided informed written consent.

Exclusion Criteria:

Severe cognitive impairment or communication difficulties that prevent questionnaire completion.

Refusal to participate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measuring the prevalence of depressive symptoms among cardiovascular patients assessed by SCL-90R
Time Frame: Within 12 months

The Symptom Checklist-90-Revised (SCL-90R) will be used to assess depression subscale scores among patients with cardiovascular diseases. A predefined cutoff score indicates the presence of depressive symptoms.

Unit of measure: Percentage of participants with depressive symptoms (%)
Within 12 months
Measuring the prevalence of anxiety symptoms among cardiovascular patients assessed by SCL-90R
Time Frame: Within 12 months

Anxiety subscale of SCL-90R will be used to quantify anxiety symptoms in patients.

Unit of measure : Percentage of participants with anxiety symptoms (%)
Within 12 months
Prevalence of burnout among healthcare providers assessed by Maslach Burnout Inventory (MBI)
Time Frame: Within 12 months

The Maslach Burnout Inventory (MBI) will be used to assess emotional exhaustion, depersonalization, and personal accomplishment among cardiology staff.

Unit of measure : Percentage of participants meeting burnout criteria (%)
Within 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Association between sociodemographic and clinical factors and psychiatric symptoms
Time Frame: within 12 months

Multivariate logistic regression will be used to identify predictors (e.g., age, sex, job type, disease severity) associated with depression, anxiety, and burnout.

Unit is Odds ratio (95% CI).
within 12 months
Mean Perceived Stress Scale (PSS) score among patients and providers
Time Frame: within 12 months

Perceived Stress Scale will be used to measure stress levels; higher scores indicate greater perceived stress.

Unit of measure : Mean PSS score (0-40)
within 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Investigators

  • Study Director: Ali Mohammed Tohamy, Ass. Professor, Assiut University
  • Study Director: Ayman Khairy Hassan, Professor, Assiut University
  • Principal Investigator: Hossam Loly Abdullah, bachelor's, Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2026

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

March 1, 2028

Study Registration Dates

First Submitted

September 25, 2025

First Submitted That Met QC Criteria

December 8, 2025

First Posted (Actual)

December 10, 2025

Study Record Updates

Last Update Posted (Actual)

December 10, 2025

Last Update Submitted That Met QC Criteria

December 8, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • psychiatry in cardiology

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burnout

Clinical Trials on Psychological Assessment using Validated Questionnaires

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe